Xovoltib 40mg Tablets

Xovoltib 40mg Tablets Specification

Indication
Non-Small Cell Lung Cancer (NSCLC)

Origin
India

Dosage Form
Tablet

Salt Composition
Afatinib Dimaleate 40mg

Feature
Tyrosine Kinase Inhibitor; Oral Administration

Application
Prescription Oncology Medication

Physical Color/Texture
Light Yellow, Film-Coated Tablets

Fermentation Smell
Odorless

Storage Instructions
Cool & Dry Place

Shelf Life
24 Months

Pack Size
28 tablets per box

Packaging Type
Blister Pack

Warning
To be used under medical supervision

Prescription Requirement
Prescription Only

Route of Administration
Oral

ATC Classification
L01EB03

Strength
40mg per tablet

Xovoltib 40mg Tablets Trade Information

Minimum Order Quantity
5000 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
3-4 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Xovoltib 40mg Tablets

Xovoltib is used to treat non-small cell lung cancer (NSCLC) that is metastatic (spread to other parts of your body besides your lungs), and has abnormal epidermal growth factor (EGF) receptor genes. These abnormal genes promote the growth of cancer cells

Key Features of Xovoltib 40mg Tablets

Xovoltib 40mg harnesses the power of Afatinib Dimaleate, classified under ATC code L01EB03 as a tyrosine kinase inhibitor. Designed as light yellow, film-coated, and odorless tablets, Xovoltib delivers precision cancer therapy for patients with NSCLC. It comes in a secure blister pack to ensure quality and patient safety throughout its shelf life.

Usage and Administration Guidelines

Xovoltib should be taken orally as prescribed by a healthcare professional. The dosage and duration are determined by your doctor based on individual clinical needs. Always store the tablets in a cool, dry place, and keep them out of reach of children. Never self-medicate; medical supervision is mandatory for this potent therapy.

Prescription and Safety Information

Because Afatinib Dimaleate is a targeted therapy for NSCLC, Xovoltib is only available with a valid prescription. Ensure regular follow-ups with your oncology team to monitor your response and manage any side effects. The tablets do not have a fermentation smell and should retain their light yellow appearance until expiry.

FAQ's of Xovoltib 40mg Tablets:

Q: How should I take Xovoltib 40mg Tablets for best results?

A: Xovoltib 40mg Tablets should be administered orally, exactly as prescribed by your healthcare provider. Take the tablet whole with water, preferably at the same time each day, and follow your doctor's instructions regarding meals and timing.

Q: What conditions does Xovoltib 40mg treat?

A: Xovoltib 40mg is indicated for the treatment of non-small cell lung cancer (NSCLC) and works by inhibiting specific tyrosine kinases involved in cancer cell growth and survival.

Q: When is Xovoltib 40mg not recommended for use?

A: Xovoltib 40mg should not be used without a doctor's prescription or supervision. Discuss with your healthcare provider if you have allergies to Afatinib Dimaleate or experience severe side effects during treatment.

Q: Where should I store Xovoltib 40mg Tablets to maintain potency?

A: Store Xovoltib 40mg Tablets in a cool and dry place, away from direct sunlight and moisture. Always keep the tablets in their original blister packaging until use.

Q: What is the process for obtaining Xovoltib 40mg Tablets?

A: You need a valid prescription from a licensed medical practitioner to obtain Xovoltib 40mg Tablets. They are available via prescription oncology suppliers and exported by certified traders in India.

Q: What are the main benefits of using Xovoltib 40mg in NSCLC patients?

A: Xovoltib 40mg targets and inhibits growth signals in cancer cells, helping to slow disease progression and improve clinical outcomes for selected NSCLC patients, as determined by your oncologist.

Q: Is it necessary to complete the entire box of Xovoltib 40mg Tablets?

A: Always follow your oncologist's instructions regarding duration. Do not stop or alter the course unless advised, as continuous dosing may be essential for optimal benefit in cancer therapy.

Tell us about your requirement